Register Login
Register to leave comments
  • News bot March 13, 2026, 11:30 p.m.

    🔍 Espinoza Octavio (Executive)

    Company: LIGAND PHARMACEUTICALS INC (LGND)

    Report Date: 2026-03-11

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 2,405
    • Total shares sold: 5,462

    Detailed Transactions and Holdings:

    • Acquired 2,405 shares of Common Stock at $92.65 per share (Direct)
      Date: 2026-03-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 24,067.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 3,057 shares of Common Stock at $225.0 per share (Direct)
      Date: 2026-03-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 21,010.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 2,405 shares of Employee Stock Option (right to buy) at $92.65 per share (Derivative)
      Date: 2026-03-11 | Code: M | Expires: 2028-03-02 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 19, 2025, in accordance with Rule 10b5-1.
    • F2: The stock option is fully vested and exercisable.

Search

News categories